At Rebirth Women’s Clinic, we provide advanced embryo genetic screening options such as PGT-A, NICS, and NiPGS to improve IVF success and ensure healthier pregnancy outcomes. These non-invasive and highly accurate screening technologies help identify chromosomal abnormalities in embryos, increasing the chances of a successful implantation and reducing the risk of miscarriage.
Genetic screening evaluates embryos for chromosomal abnormalities before implantation. It is especially useful for couples undergoing IVF, women of advanced maternal age, those with recurrent pregnancy loss, or couples with known genetic conditions.
At Rebirth Women’s Clinic, we offer three advanced options:
PGT-A – Preimplantation Genetic Testing for Aneuploidies
NICS – Non-Invasive Chromosomal Screening
NiPGS – Non-Invasive Preimplantation Genetic Screening
PGT-A involves testing a few cells from the embryo (blastocyst stage) to check for chromosomal abnormalities. This procedure helps select embryos with normal chromosome numbers, improving implantation rates and reducing miscarriage risk.
Accurate detection of chromosomal abnormalities
Higher successful pregnancy rates
Recommended for advanced maternal age & recurrent IVF failures
NICS is a non-invasive test that analyses DNA released by embryos into the culture medium, avoiding the need for embryo biopsy. This method is safe, gentle, and provides reliable chromosomal information.
Completely non-invasive, no embryo biopsy
Ideal for patients wanting safer embryo evaluation
Helps differentiate normal vs abnormal embryos
NiPGS is an advanced version of non-invasive embryo testing that provides a detailed chromosomal assessment using DNA from the embryo culture fluid. It offers high accuracy similar to traditional biopsy-based testing.
High accuracy without embryo harm
Better embryo selection for transfer
Reduces miscarriage and genetic risks
Latest technology for non-invasive and biopsy-based screening
Improved embryo selection and IVF success rates
Expert guidance from Dr. Swati Badgire throughout the process
Reduces risk of genetic disorders and early pregnancy loss
Safe, accurate, and patient-friendly testing